Diabetic Nephropathy

Research

Current research at Mayo Clinic in diabetic nephropathy includes:

• Clinical trials to develop novel therapies
• Development of genetic tests to assist in the diagnosis of diabetic nephropathy
• Development of novel diagnostic tools for earlier diagnosis of diabetic nephropathy

Nephrologists from the Diabetic Nephropathy Clinic at Mayo Clinic in Minnesota have recently completed recruitment for a multi-center trial sponsored by the National Institutes of Health; the trial will evaluate the use of Pirefenidone in the treatment of diabetic nephropathy. New treatment trials for diabetic nephropathy are being developed and conducted.

For information on Mayo Clinic research on diabetic nephropathy, see the Nephrology and Hypertension Division research web site.

For a quick survey of recent Mayo publications on diabetic nephropathy, click to visit PubMed, a service of the National Library of Medicine.